Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (18)

2024

  1. Ligand bias and inverse agonism on 5-HT2A receptor-mediated modulation of G protein activity in post-mortem human brain

    British Journal of Pharmacology

2023

  1. Isolation and Differentiation of Neurons and Glial Cells from Olfactory Epithelium in Living Subjects

    Molecular Neurobiology, Vol. 60, Núm. 8, pp. 4472-4487

  2. Psilozibinaren administrazio akutuaren eraginen ebaluazioa garun kortexean serotonina, noradrenalina eta dopamina mailak neurtuz: garun-mikrodialisiaren bidez burututako ikerlana esna dauden saguetan

    Osasun zientziak: V. Ikergazte Nazioarteko Ikerteta Euskaraz. 2023eko maitzaren 17, 18 eta 19 Donostia, Euskal Herria.

2022

  1. Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients

    Addiction Biology, Vol. 27, Núm. 6

  2. High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers

    International Journal of Neuropsychopharmacology, Vol. 25, Núm. 6, pp. 468-478

  3. Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response

    Biomedicine and Pharmacotherapy, Vol. 154

2021

  1. Enfermedades mentales y nutrición saludable. Nuevas alternativas para su tratamiento

    Revista española de nutrición comunitaria = Spanish journal of community nutrition, Vol. 27, Núm. 1

2020

  1. Pimavanserin exhibits serotonin 5-HT2A receptor inverse agonism for Gαi1- and neutral antagonism for Gαq/11-proteins in human brain cortex

    European Neuropsychopharmacology, Vol. 36, pp. 83-89

  2. Serum β-endorphin levels are associated with addiction to suicidal behavior: A pilot study

    European Neuropsychopharmacology, Vol. 40, pp. 38-51

2019

  1. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α2-adrenoceptors in the rat frontal cortex but not locus coeruleus

    Neuropharmacology, Vol. 158

2016

  1. Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study

    Psychopharmacology, Vol. 233, Núm. 23-24, pp. 3861-3867

2013

  1. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain

    European Journal of Pharmacology, Vol. 709, Núm. 1-3, pp. 13-19

  2. Chronic pain leads to concomitant noradrenergic impairment and mood disorders

    Biological Psychiatry, Vol. 73, Núm. 1, pp. 54-62

2012

  1. Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus

    Neuropharmacology, Vol. 62, Núm. 5-6, pp. 1944-1953

  2. The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain

    Psychopharmacology, Vol. 221, Núm. 1, pp. 53-65

2010

  1. Relationship between non-functional masticatory activity and central dopamine in stressed rats

    Journal of Oral Rehabilitation, Vol. 37, Núm. 11, pp. 827-833

2009

  1. Bases neurobiológicas de la depression

    Salud(i)Ciencia, Vol. 16, Núm. 8, pp. 835-838

2008

  1. EFFECTS OF SUBCHRONIC CORTICOSTERONE TREATMENT IN THE FUNCTIONAL ACTIVITY OF ALPHA 2-ADRENOCEPTORS IN RAT BRAIN CORTEX

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY